Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dna X (SONM) EBT Margin (2018 - 2025)

Dna X filings provide 8 years of EBT Margin readings, the most recent being 28.76% for Q3 2025.

  • On a quarterly basis, EBT Margin fell 1282.0% to 28.76% in Q3 2025 year-over-year; TTM through Sep 2025 was 4.9%, a 2161.0% increase, with the full-year FY2024 number at 5.66%, down 597.0% from a year prior.
  • EBT Margin hit 28.76% in Q3 2025 for Dna X, up from 65.56% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 116.66% in Q4 2024 to a low of 75.32% in Q1 2021.
  • Median EBT Margin over the past 5 years was 28.76% (2025), compared with a mean of 21.27%.
  • Biggest five-year swings in EBT Margin: surged 12714bps in 2022 and later tumbled -6256bps in 2023.
  • Dna X's EBT Margin stood at 73.96% in 2021, then surged by 172bps to 53.18% in 2022, then crashed by -118bps to 9.38% in 2023, then surged by 1343bps to 116.66% in 2024, then crashed by -125bps to 28.76% in 2025.
  • The last three reported values for EBT Margin were 28.76% (Q3 2025), 65.56% (Q2 2025), and 3.53% (Q1 2025) per Business Quant data.